Concepedia
Statistics
Publications
3
Citations
219
H-Index
Active since
2017
Affiliations
Newcastle University(Current)
Imperial College London
AstraZeneca (United Kingdom)
Richard A. Noble is an author at Newcastle University specializing in pharmacology, medicine, and oncology.
Publications per year
2017–2023
Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma
Richard A. Noble, Natalie Bell, Helen J. Blair et al. · Haematologica · 2017 · 156 citations · Full text
Medicine, Oncology, Pharmacology +11
Simultaneous targeting of glycolysis and oxidative phosphorylation as a therapeutic strategy to treat diffuse large B-cell lymphoma
Richard A. Noble, Huw D. Thomas, Yan Zhao et al. · British Journal of Cancer · 2022 · 49 citations · Full text
Medicine, Oncology, Pharmacology +17
Targeting Cytotoxic Agents through EGFR-Mediated Covalent Binding and Release
Pasquale A. Morese, Nahoum G. Anthony, Michael S. Bodnarchuk et al. · Journal of Medicinal Chemistry · 2023 · 14 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +13
1–3 of 3